Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaëtan MacGrogan

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
NPJ Breast Cancer|April 17, 2021
Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohortThomas Grinda, Natacha Joyon, Amélie Lusque, et al.
Annales De Pathologie|July 2, 2019
[GEFPICS' guidelines for management of breast cancer tissue samples in the neoadjuvant setting]Aurélie Maran-Gonzalez, Camille Franchet, Raphaëlle Duprez-Paumier, et al.
BMC Cancer|July 24, 2013
SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 casesJocelyne Jacquemier, Frédérique Spyratos, Benjamin Esterni, et al.
Annales De Pathologie|August 16, 2021
[2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France]Camille Franchet, Lounes Djerroudi, Aurélie Maran-Gonzalez, et al.
Annales De Pathologie|December 3, 2014
[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France]Frédérique Penault-Llorca, Anne Vincent-Salomon, Gaëtan MacGrogan, et al.
Annales De Pathologie|December 3, 2014
[Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France]Gaëtan MacGrogan, Marie-Christine Mathieu, Bruno Poulet, et al.
Nature Communications|July 14, 2016
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancersAnthony Ferrari, Anne Vincent-Salomon, Xavier Pivot, et al.
Nature Communications|September 27, 2016
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltrationMarcel Smid, F Germán Rodríguez-González, Anieta M Sieuwerts, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
NPJ Breast Cancer|April 17, 2021
Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohortThomas Grinda, Natacha Joyon, Amélie Lusque, et al.
Annales De Pathologie|July 2, 2019
[GEFPICS' guidelines for management of breast cancer tissue samples in the neoadjuvant setting]Aurélie Maran-Gonzalez, Camille Franchet, Raphaëlle Duprez-Paumier, et al.
BMC Cancer|July 24, 2013
SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 casesJocelyne Jacquemier, Frédérique Spyratos, Benjamin Esterni, et al.
Annales De Pathologie|August 16, 2021
[2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France]Camille Franchet, Lounes Djerroudi, Aurélie Maran-Gonzalez, et al.
Annales De Pathologie|December 3, 2014
[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France]Frédérique Penault-Llorca, Anne Vincent-Salomon, Gaëtan MacGrogan, et al.
Annales De Pathologie|December 3, 2014
[Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France]Gaëtan MacGrogan, Marie-Christine Mathieu, Bruno Poulet, et al.
Nature Communications|July 14, 2016
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancersAnthony Ferrari, Anne Vincent-Salomon, Xavier Pivot, et al.
Nature Communications|September 27, 2016
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltrationMarcel Smid, F Germán Rodríguez-González, Anieta M Sieuwerts, et al.
Pageof 8